The Chemours Company $CC Shares Sold by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd cut its stake in The Chemours Company (NYSE:CC) by 72.5% during the first quarter, HoldingsChannel reports. The institutional investor owned 55,592 shares of the specialty chemicals company’s stock after selling 146,771 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Chemours were worth $1,225,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CC. Oregon Public Employees Retirement Fund increased its stake in Chemours by 1.8% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 34,300 shares of the specialty chemicals company’s stock worth $404,000 after buying an additional 600 shares in the last quarter. PFG Investments LLC lifted its position in shares of Chemours by 7.6% in the fourth quarter. PFG Investments LLC now owns 12,494 shares of the specialty chemicals company’s stock valued at $147,000 after acquiring an additional 883 shares in the last quarter. State of Alaska Department of Revenue boosted its stake in shares of Chemours by 1.2% in the fourth quarter. State of Alaska Department of Revenue now owns 76,257 shares of the specialty chemicals company’s stock worth $899,000 after acquiring an additional 932 shares during the last quarter. Man Group plc boosted its stake in shares of Chemours by 0.4% in the second quarter. Man Group plc now owns 271,108 shares of the specialty chemicals company’s stock worth $3,104,000 after acquiring an additional 979 shares during the last quarter. Finally, Rothschild Investment LLC increased its position in shares of Chemours by 87.0% during the fourth quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 1,255 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Chemours Trading Up 2.4%

NYSE:CC traded up $0.42 during trading hours on Friday, hitting $17.81. The company had a trading volume of 1,952,003 shares, compared to its average volume of 2,611,242. The company has a current ratio of 1.82, a quick ratio of 0.87 and a debt-to-equity ratio of 18.98. The company has a 50-day moving average of $21.73 and a 200 day moving average of $19.46. The company has a market cap of $2.68 billion, a P/E ratio of -6.75 and a beta of 1.41. The Chemours Company has a 1 year low of $10.44 and a 1 year high of $28.67.

Chemours (NYSE:CC) last posted its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.05) by $0.10. The business had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.40 billion. Chemours had a positive return on equity of 52.49% and a negative net margin of 6.82%.The company’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.13 EPS. Sell-side analysts expect that The Chemours Company will post 1.16 earnings per share for the current year.

Chemours Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Sunday, May 17th were paid a dividend of $0.0875 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $0.35 dividend on an annualized basis and a yield of 2.0%. Chemours’s payout ratio is -13.26%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Royal Bank Of Canada increased their price objective on Chemours from $26.00 to $29.00 and gave the company an “outperform” rating in a research note on Monday, May 11th. Morgan Stanley upped their target price on shares of Chemours from $17.00 to $21.00 and gave the stock an “equal weight” rating in a report on Monday, May 11th. Truist Financial increased their target price on shares of Chemours from $27.00 to $30.00 and gave the company a “buy” rating in a research report on Tuesday, April 28th. Weiss Ratings reissued a “sell (d)” rating on shares of Chemours in a research note on Monday, April 20th. Finally, Zacks Research upgraded shares of Chemours from a “strong sell” rating to a “hold” rating in a research report on Friday, April 24th. Six equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $24.10.

Chemours Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.